Elutia (ELUT) Work In Process (2019 - 2025)

Elutia (ELUT) reported Work In Process of $1.1 million for Q2 2025, up 114.66% on a YoY basis from $498000.0 in Q2 2024, and up 0.85% sequentially from $1.1 million in Q1 2025.

Elutia (ELUT) Work In Process (2019 - 2025) Analysis & Trends

Elutia (ELUT) has 7 years of Work In Process data on file, last reported at $1.1 million in Q2 2025.

  • For the quarter ending Q2 2025, Work In Process rose 114.66% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2025 stood at $1.1 million (up 114.66% YoY), and the FY2024 full-year result was $740000.0, up 158.74% from the prior year.
  • Work In Process rose to $1.1 million in Q2 2025, from $1.1 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.3 million in Q2 2021 to a low of $286000.0 in Q4 2023.
  • A 5-year average of $760777.8 and a median of $749000.0 in 2024 frame the typical range for Work In Process.
  • Across the five-year window, Work In Process slumped 54.07% in 2022 and surged 158.74% in 2024, its largest moves.
  • Tracing ELUT's Work In Process over 5 years: stood at $834000.0 in 2021, then tumbled by 35.13% to $541000.0 in 2022, then slumped by 47.13% to $286000.0 in 2023, then surged by 158.74% to $740000.0 in 2024, then soared by 44.46% to $1.1 million in 2025.
  • Business Quant data shows ELUT's Work In Process at $1.1 million in Q2 2025, $1.1 million in Q1 2025, and $740000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Elutia 39.99 Mn 11.50 Mn 1.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 1.07 Mn
Mar 31, 2025 1.06 Mn
Dec 31, 2024 740,000.00
Sep 30, 2024 758,000.00
Jun 30, 2024 498,000.00
Mar 31, 2024 433,000.00
Dec 31, 2023 286,000.00
Sep 30, 2023 781,000.00
Jun 30, 2023 937,000.00
Mar 31, 2023 737,000.00
Dec 31, 2022 541,000.00
Sep 30, 2022 617,000.00
Jun 30, 2022 576,000.00
Mar 31, 2022 568,000.00
Dec 31, 2021 834,000.00
Sep 30, 2021 1.10 Mn
Jun 30, 2021 1.25 Mn
Mar 31, 2021 907,000.00
Dec 31, 2020 708,000.00
Sep 30, 2020 846,000.00